chf

Euroscreen announces name change to Ogeda and completion of Series B financing

on 19/10/2016 11:35
New identity reflects Ogeda’s successful transition to GPCR drug discovery & development
Read more

Nexstim Plc Key Technology Patent granted in EU

on 05/10/2016 10:29
Strengthened patent estate around Nexstim’s cutting-edge technology and software
Read more

Mainstay Medical announces Half Year Financial Results

on 22/09/2016 10:33

ReActiv8-A Clinical Trial – Sustained Performance at One Year

on 20/09/2016 10:37
One-year data confirm clinically important, statistically significant, and lasting improvement in pain, disability and quality of life for people with Chronic Low Back Pain and limited treatment options
Read more

Nexstim Plc agrees the next steps of the NBT stroke de novo submission with the FDA

on 15/09/2016 15:56